Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590)

    loading  Checking for direct PDF access through Ovid


Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles